Abstract: Recent progress in glycobiology has made the synthesis of oligosaccharides of prime importance for biomedical studies. Two such syntheses are described in order to illustrate our current research in this area. The first concerns the synthesis of oligosaccharides corresponding to the capsular polysaccharide of the yeast Cryptococcos neoformans, the second is the synthesis of a highly branched octasaccharide corresponding to the cell surface lipopolysaccharide of the Gram-negative bacterium Moraxella catarrhalis. In both syntheses extensive use was made of thioglycosides as glycosyl donors or as glycosyl donor precursors.
INTRODUCTION
Oligosaccharide structures, usually linked to proteins in glycoproteins and proteoglycans or to lipids in glycolipids participate in a large number of biological processes. These involve, inter alia, bacterial and viral recognition of specific cell structures as well as immune system recognition of invasive organisms. They are also involved in autoimmune processes. The enormous structural variability possible in oligosaccharide structures is the probable reason for Nature using them for the purpose of molecular recognition.
Determination of cell
Determination of Advances in biology, structural carbohydrate chemistry, and emerging knowledge of structure-activity relationships have made access necessary to these structures and to analogues of them. Thus, correlation of chemical structure with immunological specificity will clarify structure-activity relationships. Based on this knowledge, the relevant oligosaccharide may then be obtained either by suitable degradation and isolation from a natural source, or by synthesis. Transformation of the oligosaccharide into a glycoconjugate may then yield a specific diagnostic material, a non-toxic and highly specific vaccine, or a therapeutic product ( Fig. 1) 
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Considerable progress has been made in the last few years in the chemical synthesis of oligosaccharides and glycoconjugates. In the present review, two examples will be given of current research in our laboratory on syntheses of oligosaccharides of biomedical relevance.
SYNTHESES OF OLIGOSACCHARIDES CORRESPONDING TO CAPSULAR STRUCTURES OF CRYPTOCOCCUS NEOFORMANS
In humans with a fully functional immune system, the yeast Cryptococcus neofonnans does not present much danger of infection. However, in patients with compromised immune systems such as in those with AIDS, resulting from HIV disease, infections by this opportunistic organism is a most serious and often terminal event. In biomedical studies of this disease, it became necessary to have access to oligosaccharides of defined structure obtainable by chemical synthesis.
A generalized structure for Cryptococcus neofonnans serotypes A, B, C, D, and A-D is shown in Fig.2 : P -D-glucopyranosyluronic acid residues. Also, depending on the serogroups, 0-a c e r y l groups, 2-10% by weight are present in the 6-positions of the mannosyl residues. The polysaccha-rides are not strictly regular. Several oligosaccharides corresponding to these structures have now been made. Syntheses of structures I , 11, and I11 ( Fig. 3 ), all containing a mannotriosyl backbone but differing in the glycosyl group on the central mannose (compounds I and 11) and in having acetyl groups at the primary positions of the three mannoses (compound 111) are discussed here. They were required for immunological studies and as NMR reference compounds in structural studies of Crypiococcus neofonnans capsular polysaccharides.
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The syntheses of these three oligosaccharides are summarized in Fig. 4 . Monomeric starting materials were the thioglycoside and glycosyl bromide donors 1,7, and 6 respectively, and the acceptor 2. Starting materials in all three syntheses were the thioglycoside mannosyl donor 1 and the 3-OH mannoside acceptor 2. Condensation using dimethyl(methy1thio)sulfonium triflate (DMTST) as promotor yielded the disaccharide 3 which was debenzoylated to give the 2',3' diol 4. To avoid excessive protecting group manipulation, diol4 was subjected to stannylidene activation with dibutyltin oxide. Glycosidation of this intermediate with thioglycoside 1, again under promotion with DMTST then gave the pivotal mannotriose 5 with a free 2'-OH. The corresponding 1+2 linked isomer was not present in the reaction mixture. If stannylidene activation was omitted and equimolar amount of 1 and 4 were used, the trisaccharide 5 was obtained in a similar yield, but due to the added presence of the 1+2 linked isomer from mannosylation at 0 ' -2 of compound 4, chromatographic purification was more cumbersome. Fig. 4 . Syntheses of Cryptococcus neofonnans oligosaccharides Condensation of the 2'-OH compound 5 with benzobromoxylose 6 under promotion with silver triflate gave the tetrasaccharide 8. Deprotection by first debenzoylation and then catalytic hydrogenolysis then produced the target compound I in 77% yield from 8. In order to obtain the second target compound 2, the 2'-OH compound 5 was glycosylated with the thioglycoside donor 7 to produce the tetrasaccharide 9 which after deprotection by catalytic hydrogenolysis, debenzoylation and saponification was obtained as the ammonium salt I1 in 68% yield from 9. In the route to target compound 111, the three benzylidene groups were removed by mild acid treatment to leave free 4-and 6-OH groups on all three mannoses. Partial acetylation with acetyl chloride and collidine in dichloromethane then produced the 6,6',6"-triacetate 11, which upon catalytic hydrogenolysis produced the target compound I11 in 77% yield from 11.
The facile access to the trisaccharide 5 using a minimum of protecting group manipulation thus made it possible to obtain the three target compounds I, 11, and I11 from the same precursor.
SYNTHESIS OF AN OCTASACCHARIDE CORRESPONDING TO PART OF THE OUTER CELL WALL STRUCTURE OF MORAXELLA CATARRHALZS SEROTYPE A
The Gram negative bacterium Moraxella catarrhalis is now recognized as a common cause of respiratory tract and middle ear infections. In order to develop diagnostics and vaccines, oligosaccharides were needed corresponding to its outer cell wall lipopolysaccharide structure shown in Fig. 5 . Several oligosaccharides corresponding to the right-hand part of the structure have been made, all glycosidically linked to a spacer which makes attachment to proteins possible, thereby obtaining artificial antigens. Here will be described the synthesis of an octasaccharide comprising the structure shown, but without the two 3-deoxy-D-mannooctulosonic acid units (Fig. 5) . The synthesis started from the disaccharide thioglycoside 12 available from previous work. Its benzoyl groups were replaced with benzyls and the product 13 was then attached by an a-D-glycosidic bond to the p-trifluoroacetamido spacer using DMTST in ether, taking advantage of a non-participating benzyl group at 0-2. Mild acidic hydrolysis removed the benzylidene group in 14 to give the 2,3-diol 15 which was converted into the 6-0-tert.butyldimethylsily1 ether (TBDMS ether) 16. Silver triflate promoted glycosylation with 3,4,6-tri-0-benzyl-2-O-chloroacetyl-a-D-glucopyranosyl bromide 18, obtained in turn from the thioglycoside 17 produced the trisaccharide 19, from which the monochloroacetyl group was removed, giving 20, which now was glycosylated with 3,4,6-tri-O-acetyl-2-azido-2-deoxy-a-Dglucopyranosyl bromide (22), in turn obtained from the thioglycoside 21, using silver triflate promotion to obtain the tetrasaccharide. The TBDMS group in the product 23 was removed and the 6-OH compound 24 was glycosylated with the glycosyl bromide 18 (above) under silver triflate promotion. The chloroacetyl group in the product 25 was removed by hydrazinedithiocarbonate without removing the three acetyl groups. The pentasaccharide 25 is the first major building block in the synthesis. There now remained the synthesis of the trisaccharide building block. Thiomethyl P-lactoside (27) was 4,6'-benzylidenated and the product 28 was then fully benzylated to give 29. Regioselective reductive opening of the benzylidene group in 29 the gave the 4'-OH compound 30 which was glycosylated under silver triflate promotion with the galactosyl chloride 31. The thioglycoside 32 was converted into the bromo sugar 33 (Fig. 6 ). Finally the two blocks 26 and 33 were condensed in diethyl ether in the presence of silver triflate to produce the final a-D-glycosidic linkage and 282 mg of the octasaccharide 34. The final steps in the synthesis were: (1)
Deacetylation with NaOMe-MeOH. (2) Catalytic hydrogenolysis to remove the benzyl groups and to reduce the azido group to an amino group. (3) N-acetylation by treatment with Ac20 in MeOH. The total yield for these last 3 steps, including chromatographic purification was 36%. 
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